Press releasePRNewswire
Atrium Therapeutics
RNA · NASDAQ
$7.98+$0.37 (+4.86%)TodayMarket closed ·
Prev close $7.61
Latest news
- Press releasePRNewswire
Yakira Capital Management Calls on Atrium Therapeutics to Launch Strategic Review, Curb Cash Spending and Explain Dilutive Financing
- Press releasePRNewswire
Atrium Therapeutics Announces $50 Million Private Placement
- Press releasePRNewswire
Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Press releasePRNewswire
Atrium Therapeutics to Participate in Upcoming Investor Conferences
- Press releasePRNewswire
Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Press releasePRNewswire
Atrium Therapeutics Reports Second Quarter 2026 Financial Results
- Press releasePRNewswire
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
- Press releasePRNewswire
Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Press releasePRNewswire
Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome
- Press releasePRNewswire
Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Press releasePRNewswire
Atrium Therapeutics Reports First Quarter 2026 Financial Results
- Press releasePRNewswire
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
- Press releasePRNewswire
Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Press releasePRNewswire
Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies
- NewsAvi Kapoor
Why Applied Optoelectronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
- Press releasePRNewswire
Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
- Press releasePRNewswire
Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders
- Press releasePRNewswire
The New England Journal of Medicine Publishes Results from Phase 1/2 MARINA® Trial of Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1
- Press releasePRNewswire
Avidity Biosciences Announces Expected Record Date for Spin-Off
- Press releasePRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--TBHC, RNA, NEW, and TWO
- NewsHillary Remy
The Year-End 2025 Biotech Rally And What It Means For 2026
- Press releasePRNewswire
Halper Sadeh LLC Encourages RNA, TCBX, ATXS, FSUN Shareholders to Contact the Firm to Discuss Their Rights
- Press releasePRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--TCBX, RNA, ATXS, and FSUN
- Press releasePRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-WTRG, RNA, FIZN, and TCBX
- NewsVandana Singh
Novartis Projects Faster Growth Through 2030 After Raising Drug Forecasts
- Press releasePRNewswire
Avidity Biosciences Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota in DMD44
- Press releasePRNewswire
Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights
- NewsAvi Kapoor
Nucor To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Tuesday
- NewsAvi Kapoor
This Boot Barn Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
- NewsVandana Singh
Novartis Maintains Outlook Even As Generics Bite Into Profits
- NewsNamrata Sen
'Merger Monday' Makes Comeback As US M&A Tops $80 Billion In 24 Hours
- NewsTriveni Kothapalli
Avidity Biosciences Soars After $72 Per Share Novartis Takeover
- NewsRishabh Mishra
Stock Market Today: Nasdaq, Dow Jones, S&P 500 Futures Climb Ahead Of Busy Week On Wall Street—Novartis, Nucor, Waste Management In Focus (UPDATED)
- NewsAvi Kapoor
IBEX, Tesla, IonQ, Warner Bros. Discovery And Other Big Stocks Moving Higher On Friday
- NewsAvi Kapoor
Nasdaq Jumps Over 150 Points; Kroger Earnings Top Estimates
- NewsAvi Kapoor
Why Oxford Industries Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.